Oncology
Oncology
About this Gateway
Scope
From prevention to diagnosis, treatment to survivorship, it is essential that all cancer research and underlying data is available rapidly and without restrictions to decision makers.
The Oncology Gateway brings together all research outputs from cancer research and welcomes submissions in all areas of Oncology research, including:
Eligibility
Submission is open to all those involved in cancer research.
Collections Currently Open for Submissions:
Radiomics (Guest Advisor: Dr Alberto Traverso)
Equitable Cancer Care (Guest Advisor: Dr Matthew Schabath)
Childhood Cancer (Guest Advisor: Dr Ana Banito)
Bioinformatics in Cancer Research (Guest Advisors: Dr Jacob Luber, Dr Rongling Wu, Dr Li Zhang)
Computational Cancer Systems Biology (Guest Advisor: Dr Fabian Froehlich)
Cancer Pain Management
Submission deadline: 9th February 2024
Breakthroughs in Myelodysplastic Syndromes
Submission deadline: 8th March 2024
From prevention to diagnosis, treatment to survivorship, it is essential that all cancer research and underlying data is available rapidly and without restrictions to decision makers.
The Oncology Gateway brings together all research outputs from cancer research and welcomes submissions in all areas of Oncology research, including:
- Biology: biomarkers, genetics, genomics and epigenetics, systems biology, metabolism
- Diagnosis & Prognosis: imaging, biopsy, predictive factors, demographic, behavioral, disease-specific, comorbidities
- Surgery & Therapy: radiation oncology, surgical oncology, immunotherapy, cell therapy, stem cells, chemotherapy
- Epidemiology & Prevention: infectious agents and vaccines, early detection, genetic and environmental risk factors,
- Survivorship: late effects, disease reoccurrence, quality of life, economic impact of cancer
Eligibility
Submission is open to all those involved in cancer research.
Collections Currently Open for Submissions:
Radiomics (Guest Advisor: Dr Alberto Traverso)
Equitable Cancer Care (Guest Advisor: Dr Matthew Schabath)
Childhood Cancer (Guest Advisor: Dr Ana Banito)
Bioinformatics in Cancer Research (Guest Advisors: Dr Jacob Luber, Dr Rongling Wu, Dr Li Zhang)
Computational Cancer Systems Biology (Guest Advisor: Dr Fabian Froehlich)
Cancer Pain Management
Submission deadline: 9th February 2024
Breakthroughs in Myelodysplastic Syndromes
Submission deadline: 8th March 2024
Gateway Areas
The Biology area focusses on the relationship between genes, proteins and biological systems that drive the development and growth of cancers. Publishing research on biomarkers, genetics, genomics and epigenetics, systems biology and metabolism, among other topics, understanding the biological development of cancer is essential to identify new treatment targets.
The Epidemiology & Prevention area disseminates research on the risk factors associated with cancer development and the interventions to minimise this risk. Topics covered include infectious agents and vaccines, social determinants of health, disparities of cancer, genetic and environmental factors, behavioural determinants of health, early detection, screening and preventative interception.
The Diagnosis & Prognosis area focusses on accurate and early detection of cancer through imaging and biopsies, as well as the likely progression and survival rates of different type, stage and grades of cancer.
The Surgery & Therapy area focusses on disseminating research on all types of cancer treatment. In particular, radiation oncology, surgical oncology, immunotherapy, cell therapy, stem cells and chemotherapy.
The Survivorship area focusses on disseminating research on the health and well-being of a patient from diagnosis to end of life. Topics include late effects, disease reoccurrence, quality of life and economic impact of cancer.
Gateway Advisors
-
Cheng-Ming Chiang
University of Texas Southwestern Medical Center, USA -
Jon Chernoff
Fox Chase Cancer Center, USA -
Margie Clapper
Fox Chase Cancer Center, USA -
Carolyn Fang
Fox Chase Cancer Center, USA -
Bassam Janji
Luxembourg Institute of Health, Luxembourg -
Emanuela Taioli
Icahn School of Medicine at Mount Sinai, USA